NEW STUDY: SISOLAK POLICY LIKELY KILLED NV CV19 PATIENTS

Nov 28, 2020

Rob Lauer Political Reporter

In March of this year, Gov. Sisolak banned the use of hydroxychloroquine for Nevada patients with CV19. But a new study, set to be published in the International Journal of Antimicrobial Agents in December, found that “Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”

The result was 84% fewer hospitalizations for patients treated with controversial drug hydroxychloroquine.

As reported in the Washington Examiner:

A total of 141 patients diagnosed with the coronavirus were treated with the three-drug cocktail over a period of five days and compared to a control group of 377 people who tested positive for the virus but were not given the treatment.

The study found that “the odds of hospitalization of treated patients was 84% less than in the untreated patients,” and only one patient died from the group being treated with the drugs compared to 13 deaths in the untreated group.